Adenovirus-mediated tissue-targeted expression of the CDglyTk gene for the treatment of breast cancer

Molecular Medicine Reports

Volumn 6, Issue 2, 2012, Pages 321-329

  Su, Guo Qiang ^a   Su, Gang ^b   Huang, Zong Hai ^c  

^a THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Adenovirus; Breast cancer; CDglyTK fusion gene; Gene therapy; Kinase domain containing receptor promoter; Vascular endothelium

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; GANCICLOVIR; THYMIDINE KINASE;

ADENOVIRUS; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER TISSUE; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN MCF 7; COLON CARCINOMA; CONTROLLED STUDY; CYTOMEGALOVIRUS; FUSION GENE; GENE EXPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PROTEIN EXPRESSION; SUICIDE TRANSGENE;

ADENOVIRIDAE; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYTOSINE DEAMINASE; FEMALE; FLOW CYTOMETRY; FLUCYTOSINE; GANCICLOVIR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, TRANSGENIC, SUICIDE; GENETIC VECTORS; HUMANS; MICE; MICE, NUDE; PROMOTER REGIONS, GENETIC; RECOMBINANT FUSION PROTEINS; THYMIDINE KINASE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ADENOVIRIDAE; CYTOMEGALOVIRUS; MUS MUSCULUS;

EID: 84863500124     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.925     Document Type: Article

References (25)

1. Sankaranarayanan R, Swaminathan R, Jayant K and Brenner H: An overview of cancer survival in Africa, Asia, the Caribbean and Central America: the case for investment in cancer health services. IARC Sci Publ 162: 257-291, 2011.
2. Gebbia V, Boussen H and Valerio MR: Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma. Anticancer Res 32: 529-536, 2012.
3. Mustacchi G, Cazzaniga ME, Pronzato P, et al: Breast cancer in elderly women: a different reality? Results from the NORA study. Ann Oncol 18: 991-996, 2007. (Pubitemid 47050489)
4. Cocconi G, Caminiti C, Zaninetta G, et al: National survey of medical choices in caring for terminally ill patients in Italy, a cross-sectional study. Tumori 96: 122-130, 2010.
5. Chatterjee SJ and Pandey S: Chemo-resistant melanoma sensitized by tamoxifen to low dose curcumin treatment through induction of apoptosis and autophagy. Cancer Biol Ther 11: 216-228, 2011.
6. Kim KY, Kim SU, Leung PC, et al: Influence of the prodrugs 5-fluorocytosine and CPT-11 on ovarian cancer cells using genetically engineered stem cells: tumor-tropic potential and inhibition of ovarian cancer cell growth. Cancer Sci 101: 955-962, 2010.
7. Tai CK, Wang W, Lai YH, et al: Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene. Cancer Gene Ther 17: 614-623, 2010.
8. Kucerova L, Matuskova M, Hlubinova K, et al: Bystander cytotoxicity in human medullary thyroid carcinoma cells mediated by fusion yeast cytosine deaminase and 5-fluorocytosine. Cancer Lett 311: 101-112, 2011.
9. Cottin S, Gould PV, Cantin L, et al: Gap junctions in human glioblastomas: implications for suicide gene therapy. Cancer Gene Ther 18: 674-681, 2011.
10. Vernimmen D, Gueders M, Pisvin S, et al: Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers. Br J Cancer 89: 899-906, 2003. (Pubitemid 37175814)
11. Tomizawa M, Yu L, Wada A, et al: A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter. Br J Cancer 89: 1086-1090, 2003. (Pubitemid 37239216)
12. Beierle EA, Dai W, Langham MR Jr, et al: Expression of VEGF receptors in cocultured neuroblastoma cells. J Surg Res 119: 56-65, 2004. (Pubitemid 38581986)
13. Siemann DW and Shi W: Efficacy of combined antiangiogenic and vascular disrupting agents in treatment of solid tumors. Int J Radiat Oncol Biol Phys 60: 1233-1240, 2004. (Pubitemid 39440810)
14. Ma J, Li M, Mei L, et al: Double suicide genes driven by kinase domain insert containing receptor promoter selectively kill human lung cancer cells. Genet Vaccines Ther 9: 1-6, 2011.
15. Yu Z, Wang H, Zhang L, et al: Both p53-PUMA/NOXA-Bax-mitochondrion and p53-p21cip1 pathways are involved in the CDglyTK-mediated tumor cell suppression. Biochem Biophys Res Commun 386: 607-611, 2009.
16. Yang D, Yang J, Lu F, et al: A new membrane re-anchored protein originating from GPC3 against hepatoma cells HepG2. Mol Med Report 4: 1067-1073, 2011.
17. Huber BE, Austin EA, Good SS, et al: In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res 53: 4619-4626, 1993. (Pubitemid 23304389)
18. Weidner N, Folkman J, Pozza F, et al: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84: 1875-1887, 1992 (Pubitemid 23004615)
19. Mauro LV, Bellido M, Morandi A, et al: Association between mast cells of different phenotypes and angiogenesis in colorectal cancer. Mol Med Report 1: 895-902, 2008.
20. Oh JY, Park MY, Kim DR, et al: Combination gene therapy of lung cancer with conditionally replicating adenovirus and adenovirus-herpes simplex virus thymidine kinase. Int J Mol Med 25: 369-376, 2010.
21. Ge YL, Zhang JY, Zhang X, et al: Chemically modified siRNA directed against the KDR gene inhibits the proliferation of breast cancer cells. Mol Med Report 2: 121-127, 2009.
22. Szary J, Kalita K, Przybyszewska M, et al: KDR promoter can transcriptionally target cytosine deaminase suicide gene to cancer cells of nonendothelial origin. Anticancer Res 21: 3471-3475, 2001. (Pubitemid 34224253)
23. Rogulski KR, Wing MS, Paielli DL, et al: Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization. Hum Gene Ther 11: 67-76, 2000. (Pubitemid 30044041)
24. Qiu Y, Peng GL, Liu QC, et al: Selective killing of lung cancer cells using carcinoembryonic antigen promoter and double suicide genes, thymidine kinase and cytosine deaminase (pCEA-TK/CD). Cancer Lett 316: 31-38, 2012.
25. Fischer U, Steffens S, Frank S, et al: Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/5-fluorocytosine suicide gene therapy-induced cell death in glioma cells. Oncogene 24: 1231-1243, 2005. (Pubitemid 40313924)